Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Day Two Helpful Hints from the Generic Drug Forum 2026

    The second day of the Generic Drugs Forum provided a significant amoun...
    Read More

    More Tidbits from Day One of the Generic Drug Forum 2026

    Here are some helpful tips and reminders regarding ANDA submissions, p...
    Read More
    A Few Tidbits from the Generic Drugs Forum (GDF) 2026 Morning Sessions

    A Few Tidbits from the Generic Drugs Forum (GDF) 2026 Morning Sessions

    The Generic Drugs Forum for 2026 got off to a great start this morning...
    Read More

    Beyond the Bot: FDA’s AI Wake-Up Call for Biopharma

    The FDA’s April 2, 2026 Warning Letter to a cosmetics company mark...
    Read More

    OGD’s Official March 2026 Statistical Report Just Issued

    The approval metrics look very similar to previous months during this ...
    Read More

    Mid-April 2026 Unofficial ANDA Approval Actions – Holy Cow!

    The number of approval actions that were posted for the first half of ...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today